The performance of companies tied to Sildenafil's past presents a challenging investment picture . While the initial surge generated substantial returns , generic copies have significantly impacted revenue. https://bookmarkyourpage.com/story7158732/copyright-s-flagship-product-and-big-pharma-a-risky-investment